In CRC, all SFs except SRSF1 and SRSF5 showed UIs of >50 % in the order of HNRNPA1 (88 %), SRSF3 (74 %), and other SFs (31 %–57 %). This evidence concerns the gene SRSF3 and colorectal carcinoma.